<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82131">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01686048</url>
  </required_header>
  <id_info>
    <org_study_id>Ambrosia</org_study_id>
    <nct_id>NCT01686048</nct_id>
  </id_info>
  <brief_title>The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ambrosia is known for its allergenicity in the USA causing hay fever and asthma. Israel has
      always been considered &quot;clean&quot; of Ambrosia but over the past years growth of Ambrosia plants
      has been detected in several locations in Israel.

      In the proposed study, patients referred for routine allergic evaluation will also be skin
      tested with Ambrosia allergens, in addition to their regular prick skin tests with all other
      airborne allergens.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2012</start_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Allergic Rhinitis</condition>
  <condition>Asthma</condition>
  <condition>Allergic Conjunctivitis</condition>
  <condition>Atopic Dermatitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients refered for allergic evaluation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with allergic rhinitis, asthma, allergic conjunctivitis or atopic dermatitis
             who undergo prick skin tests with airborne allergens
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Arnon Goldberg, M.D.</last_name>
    <phone>972-9-7472717</phone>
    <email>arnong@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Arnon Goldberg, M.D., Allergy and Clinical Immunology Unit, Meir Medical Center</name>
      <address>
        <city>Kfar-Saba</city>
        <zip>44281</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ronit Confino-Cohen, M.D.</last_name>
      <phone>972-9-7472811</phone>
      <email>ronitco@clalit.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 14, 2012</lastchanged_date>
  <firstreceived_date>September 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>Arnon Goldberg</investigator_full_name>
    <investigator_title>Head, Allergy and Clinical Immunology Unit</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Conjunctivitis</mesh_term>
    <mesh_term>Conjunctivitis, Allergic</mesh_term>
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Rhinitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
